Tsukuba, Japan

Masayuki Shirakura

This inventor holds 1 USPTO granted patent. Top assignee: Dna Vec Research Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Shirakura. Retrieved from https://idiyas.com/inventor/masayuki-shirakura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masayuki Shirakura: Innovator in Gene Therapy

Introduction

Masayuki Shirakura is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of gene therapy, particularly through his innovative work with viral vectors. His research focuses on the efficient transfer of nucleic acids into nerve cells, which has important implications for medical treatments.

Latest Patents

Shirakura holds a patent for "Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci." This invention utilizes a negative-sense RNA virus vector to facilitate the transfer of nucleic acid into nerve cells. The method developed by Shirakura can be effectively used for introducing genes into nerve cells, including central nerve tissue, which is crucial for advancements in gene therapy.

Career Highlights

Masayuki Shirakura is associated with Dna Vec Research Inc., where he continues to push the boundaries of genetic research. His work has garnered attention for its potential applications in treating neurological disorders and enhancing gene therapy techniques.

Collaborations

Shirakura has collaborated with notable colleagues, including Masayuki Fukumura and Makoto Asakawa. These partnerships have contributed to the advancement of research in the field of gene therapy.

Conclusion

Masayuki Shirakura's innovative work in gene therapy exemplifies the potential of viral vectors in medical science. His contributions are paving the way for new treatments and therapies that could significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…